Authors:
Hymowitz, SG
Filvaroff, EH
Yin, JP
Lee, J
Cai, LP
Risser, P
Maruoka, M
Mao, WG
Foster, J
Kelley, RF
Pan, GH
Gurney, AL
de Vos, AM
Starovasnik, MA
Citation: Sg. Hymowitz et al., IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding, EMBO J, 20(19), 2001, pp. 5332-5341
Authors:
Helman, D
Herman, A
Paly, J
Livnah, O
Elkins, PA
de Vos, AM
Djiane, J
Gertler, A
Citation: D. Helman et al., Mutations of ovine and bovine placental lactogens change, in different ways, the biological activity mediated through homologous and heterologous lactogenic receptors, J ENDOCR, 169(1), 2001, pp. 43-54
Authors:
Vajdos, FF
Ultsch, M
Schaffer, ML
Deshayes, KD
Liu, J
Skelton, NJ
de Vos, AM
Citation: Ff. Vajdos et al., Crystal structure of human insulin-like growth factor-1: Detergent bindinginhibits binding protein interactions, BIOCHEM, 40(37), 2001, pp. 11022-11029
Authors:
Elkins, PA
Christinger, HW
Sandowski, Y
Sakal, E
Gertler, A
de Vos, AM
Kossiakoff, AA
Citation: Pa. Elkins et al., Ternary complex between placental lactogen and the extracellular domain ofthe prolactin receptor, NAT ST BIOL, 7(9), 2000, pp. 808-815
Authors:
Yan, MH
Wang, LC
Hymowitz, SG
Schilbach, S
Lee, J
Goddard, A
de Vos, AM
Gao, WQ
Dixit, VM
Citation: Mh. Yan et al., Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors, SCIENCE, 290(5491), 2000, pp. 523-527
Authors:
Li, B
Fuh, G
Meng, G
Xin, XH
Gerritsen, ME
Cunningham, B
de Vos, AM
Citation: B. Li et al., Receptor-selective variants of human vascular endothelial growth factor - Generation and characterization, J BIOL CHEM, 275(38), 2000, pp. 29823-29828
Citation: G. Fuh et al., The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor Flt-1, J BIOL CHEM, 275(35), 2000, pp. 26690-26695
Authors:
Hymowitz, SG
O'Connell, MP
Ultsch, MH
Hurst, A
Totpal, K
Ashkenazi, A
de Vos, AM
Kelley, RF
Citation: Sg. Hymowitz et al., A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL, BIOCHEM, 39(4), 2000, pp. 633-640
Authors:
Hymowitz, SG
Christinger, HW
Fuh, G
Ultsch, M
O'Connell, M
Kelley, RF
Ashkenazi, A
de Vos, AM
Citation: Sg. Hymowitz et al., Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5, MOL CELL, 4(4), 1999, pp. 563-571
Citation: C. Wiesmann et Am. De Vos, Putting two and two together: crystal structure of the FGF-receptor complex, STRUCT F D, 7(11), 1999, pp. R251-R255
Authors:
Wiesmann, C
Ultsch, MH
Bass, SH
de Vos, AM
Citation: C. Wiesmann et al., Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor, NATURE, 401(6749), 1999, pp. 184-188
Authors:
Chen, Y
Wiesmann, C
Fuh, G
Li, B
Christinger, HW
McKay, P
de Vos, AM
Lowman, HB
Citation: Y. Chen et al., Selection and analysis of an optimized anti-VEGF antibody: Crystal structure of an affinity-matured Fab in complex with antigen, J MOL BIOL, 293(4), 1999, pp. 865-881
Authors:
Starovasnik, MA
Christinger, HW
Wiesmann, C
Champe, MA
de Vos, AM
Skelton, NJ
Citation: Ma. Starovasnik et al., Solution structure of the VEGF-binding domain of Flt-1: Comparison of its free and bound states, J MOL BIOL, 293(3), 1999, pp. 531-544
Authors:
Christinger, HW
Elkins, PA
Sandowski, Y
Sakal, E
Gertler, A
Kossiakoff, AA
de Vos, AM
Citation: Hw. Christinger et al., Crystallization of ovine placental lactogen in a 1 : 2 complex with the extracellular domain of the rat prolactin receptor, ACT CRYST D, 54, 1998, pp. 1408-1411